This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
payments: Archive
Here's Why Global Payments Shares Are Attracting Investors Now
by Zacks Equity Research
GPN gains investor attention with strong cash flow, acquisitions like Worldpay and the launch of its Genius platform.
GPNPositive Net Change GDOTPositive Net Change BCOPositive Net Change OPFIPositive Net Change
business-services fin-tech finance payments saas
Affirm Expands BNPL Reach With ServiceTitan & Vagaro Partnerships
by Zacks Equity Research
AFRM deepens its BNPL footprint with new ServiceTitan and Vagaro deals, expanding into home repairs, beauty, fitness and wellness services.
VPositive Net Change PYPLPositive Net Change AFRMPositive Net Change
fin-tech internet payments
Affirm vs. Block: Which Fintech Stock Has More Growth Potential?
by Kaibalya Pravo Dey
AFRM's BNPL momentum, merchant expansion and earnings growth give it stronger upside than XYZ's diversified but slower portfolio.
PYPLPositive Net Change AFRMPositive Net Change XYZNegative Net Change
fin-tech finance payments
DAVE's CAC Moves Up: Is Profitability Still in the Picture?
by Arghyadeep Bose
Dave's higher CAC is fueling strong customer growth, record EBITDA and soaring profitability despite rising costs.
DAVEPositive Net Change PMTSPositive Net Change FUTUNegative Net Change
business-services fin-tech finance payments
After Golden Cross, Strawberry Fields REIT, Inc. (STRW)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
STRWNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
American Express Expands Premium Travel With New Digital Features
by Zacks Equity Research
AXP enhances its travel edge with a new app, digital passport and smarter lounge access for card members.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
fin-tech finance payments travel-leisure
Mastercard Up 10.7% YTD, Valuation Stretched: How to Play the Stock?
by Kaibalya Pravo Dey
MA's 10.7% YTD gain, stretched valuation, strong growth drivers and regulatory hurdles leave investors weighing their next move.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
business-services fin-tech finance payments
SEZL Soars 128% in 6 Months: Is Buying Still an Option for Investors?
by Arghyadeep Bose
Sezzle's On-Demand momentum is reshaping growth metrics, with surging volumes and rising customer engagement.
MAPositive Net Change FCFSPositive Net Change SEZLNegative Net Change
business-services fin-tech finance payments tech-stocks
Should You Buy Pyxis Oncology, Inc. (PYXS) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PYXSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Howard Hughes Holdings (HHH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
HHHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Mastercard Launches AI-Powered Tools to Shape the Future of Commerce
by Zacks Equity Research
MA unveils AI-powered tools, partnerships and consulting services to shape secure, intelligent commerce for the future.
MAPositive Net Change GDOTPositive Net Change BCOPositive Net Change OPFIPositive Net Change
artificial-intelligence fin-tech finance payments
American Express & UPS Team Up to Boost SMBs During Holiday Season
by Zacks Equity Research
AXP partners with UPS to offer SMBs shipping savings and payment solutions during the busy holiday season.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
fin-tech finance payments
Can On-Demand's Popularity Continue to Help SEZL Pay Dividends?
by Arghyadeep Bose
Sezzle's On-Demand drives record user growth, surging transactions and revenues. However, rising costs test scalability.
GDOTPositive Net Change OPFIPositive Net Change SEZLNegative Net Change
business-services fin-tech finance payments
Visa Stock Drops Under 200-Day SMA: Buy, Hold or Cut the Card?
by Kaibalya Pravo Dey
V dips under key 200-day SMA, with competitive and regulatory headwinds clouding near-term sentiment.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
blockchain business-services credit-card finance payments
After Golden Cross, nCino (NCNO)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NCNOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Mastercard Unveils On-Demand Decisioning Tool for Smart Authorizations
by Zacks Equity Research
MA launches On-Demand Decisioning, a global tool giving issuers more control over approvals and boosting its digital payments strategy.
MAPositive Net Change VPositive Net Change PYPLPositive Net Change
artificial-intelligence business-services fin-tech finance payments
Harley-Davidson (HOG)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
HOGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Trip.com (TCOM) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TCOMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Visa Sustain Global Partnerships Through Renewals & Incentives?
by Zacks Equity Research
V drives growth with global partnership renewals and targeted incentives, but rising costs may test margins in a shifting payments market.
MAPositive Net Change VPositive Net Change AFRMPositive Net Change
emerging-markets fin-tech finance payments
After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
DMACNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Bull of the Day: Green Dot (GDOT)
by Shaun Pruitt
A shift toward platform-based services is starting to expand Green Dot's reach in the pro-consumer and personal banking markets.
MAPositive Net Change VPositive Net Change WMTPositive Net Change GDOTPositive Net Change PYPLPositive Net Change UBERNegative Net Change
earnings fin-tech finance investing payments
Werewolf Therapeutics, Inc. (HOWL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
HOWLNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Brixmor Property (BRX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BRXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Clean Energy Fuels (CLNE) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CLNEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy EuroDry (EDRY) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
EDRYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines